Global Aurora Kinase A Market By Product Type (AMG-900, Danusertib) And By End-Users/Application (Ovarian Cancer, Anaplastic Large Cell Lymphoma) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Aurora Kinase A market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Aurora Kinase A market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Aurora Kinase A industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Aurora Kinase A ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Aurora Kinase A market.

The following manufacturers are covered in this report:
  • AbbVie Inc.
  • Amgen Inc.
  • Astex Pharmaceuticals, Inc.
  • CASI Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Millennium Pharmaceuticals, Inc.
  • Sanofi
  • Sareum Holdings Plc
  • Sigma-Tau S.p.A.
  • Taiho Pharmaceutical Co., Ltd.
  • Vertex Pharmaceuticals Incorporated
  • Vichem Chemie Research Ltd.

The report estimates on the Aurora Kinase A market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Aurora Kinase A market report consist of all leading industry players, Aurora Kinase A business sections, company profile, revenue supply by Aurora Kinase A industry sections, global Aurora Kinase A market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Aurora Kinase A market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Aurora Kinase A market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Aurora Kinase A market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Aurora Kinase A market.

Report Opportunity: Global Aurora Kinase A Market

This report delivers an analytical examination of the Aurora Kinase A market summarized in broad sections such as
  1. Aurora Kinase A Market Summary
  2. Key Commercial Growths in the Aurora Kinase A Industry
  3. Market Dynamics Affecting the Aurora Kinase A Industry
  4. Important Market Trends and Future Development Scenario of the Aurora Kinase A Market
  5. Aurora Kinase A Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Aurora Kinase A Industry
  7. Positioning of Main Market Players in the Aurora Kinase A Industry
  8. Aurora Kinase A Market Revenue and Forecast, by Application, 2018 - 2028
  9. Aurora Kinase A Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Aurora Kinase A Market Revenue and Forecast, by Geography, 2018 - 2028
Aurora Kinase A Market Segmentation:

The report provides detailed examination of the Aurora Kinase A market on the basis of various segments such as type, application and end-use industry. The Aurora Kinase A market is segmented as follows:

Aurora Kinase A Market, by Type:
  • AMG-900
  • Danusertib
  • ENMD-2076
  • Ilorasertib
  • Others
Aurora Kinase A Market, by Application:
  • Ovarian Cancer
  • Anaplastic Large Cell Lymphoma
  • Brain Tumor
  • Others
Geographic Coverage

The report on the Aurora Kinase A market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Aurora Kinase A Market Revenue and Forecast
  • U.S.
  • Canada
Europe Aurora Kinase A Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Aurora Kinase A Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Aurora Kinase A Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Aurora Kinase A Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Aurora Kinase A Market Snapshot
          2.1.1. Global Aurora Kinase A Market By Type,2019
               2.1.1.1.AMG-900
               2.1.1.2.Danusertib
               2.1.1.3.ENMD-2076
               2.1.1.4.Ilorasertib
               2.1.1.5.Others
          2.1.2. Global Aurora Kinase A Market By Application,2019
               2.1.2.1.Ovarian Cancer
               2.1.2.2.Anaplastic Large Cell Lymphoma
               2.1.2.3.Brain Tumor
               2.1.2.4.Others
          2.1.3. Global Aurora Kinase A Market By End-use,2019
          2.1.4. Global Aurora Kinase A Market By Geography,2019

3. Global Aurora Kinase A Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Aurora Kinase A Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Aurora Kinase A Market Size (US$), By Type, 2018 – 2028

5. Global Aurora Kinase A Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Aurora Kinase A Market Size (US$), By Application, 2018 – 2028

6. Global Aurora Kinase A Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Aurora Kinase A Market Size (US$), By End-use, 2018 – 2028

7. Global Aurora Kinase A Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Aurora Kinase A Market Analysis, 2018 – 2028 
          7.2.1. North America Aurora Kinase A Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Aurora Kinase A Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Aurora Kinase A Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Aurora Kinase A Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Aurora Kinase A Market Analysis, 2018 – 2028 
          7.3.1.  Europe Aurora Kinase A Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Aurora Kinase A Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Aurora Kinase A Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Aurora Kinase A Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Aurora Kinase A Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Aurora Kinase A Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Aurora Kinase A Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Aurora Kinase A Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Aurora Kinase A Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Aurora Kinase A Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Aurora Kinase A Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Aurora Kinase A Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Aurora Kinase A Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Aurora Kinase A Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Aurora Kinase A Market Analysis, 2018 – 2028 
          7.6.1.  MEA Aurora Kinase A Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Aurora Kinase A Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Aurora Kinase A Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Aurora Kinase A Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Aurora Kinase A Providers
        8.4.1 AbbVie Inc.
                8.1.1 Business Description
                8.1.2 AbbVie Inc. Geographic Operations
                8.1.3 AbbVie Inc. Financial Information
                8.1.4 AbbVie Inc. Product Positions/Portfolio
                8.1.5 AbbVie Inc. Key Developments
        8.4.2 Amgen Inc.
                8.2.1 Business Description
                8.2.2 Amgen Inc. Geographic Operations
                8.2.3 Amgen Inc. Financial Information
                8.2.4 Amgen Inc. Product Positions/Portfolio
                8.2.5 Amgen Inc. Key Developments
        8.4.3 Astex Pharmaceuticals, Inc.
                8.3.1 Business Description
                8.3.2 Astex Pharmaceuticals, Inc. Geographic Operations
                8.3.3 Astex Pharmaceuticals, Inc. Financial Information
                8.3.4 Astex Pharmaceuticals, Inc. Product Positions/Portfolio
                8.3.5 Astex Pharmaceuticals, Inc. Key Developments
        8.4.4 CASI Pharmaceuticals Inc.
                8.4.1 Business Description
                8.4.2 CASI Pharmaceuticals Inc. Geographic Operations
                8.4.3 CASI Pharmaceuticals Inc. Financial Information
                8.4.4 CASI Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.5 CASI Pharmaceuticals Inc. Key Developments
        8.4.5 Merck & Co., Inc.
                8.5.1 Business Description
                8.5.2 Merck & Co., Inc. Geographic Operations
                8.5.3 Merck & Co., Inc. Financial Information
                8.5.4 Merck & Co., Inc. Product Positions/Portfolio
                8.5.5 Merck & Co., Inc. Key Developments
        8.4.6 Millennium Pharmaceuticals, Inc.
                8.6.1 Business Description
                8.6.2 Millennium Pharmaceuticals, Inc. Geographic Operations
                8.6.3 Millennium Pharmaceuticals, Inc. Financial Information
                8.6.4 Millennium Pharmaceuticals, Inc. Product Positions/Portfolio
                8.6.5 Millennium Pharmaceuticals, Inc. Key Developments
        8.4.7 Sanofi
                8.7.1 Business Description
                8.7.2 Sanofi Geographic Operations
                8.7.3 Sanofi Financial Information
                8.7.4 Sanofi Product Positions/Portfolio
                8.7.5 Sanofi Key Developments
        8.4.8 Sareum Holdings Plc
                8.8.1 Business Description
                8.8.2 Sareum Holdings Plc Geographic Operations
                8.8.3 Sareum Holdings Plc Financial Information
                8.8.4 Sareum Holdings Plc Product Positions/Portfolio
                8.8.5 Sareum Holdings Plc Key Developments
        8.4.9 Sigma-Tau S.p.A.
                8.9.1 Business Description
                8.9.2 Sigma-Tau S.p.A. Geographic Operations
                8.9.3 Sigma-Tau S.p.A. Financial Information
                8.9.4 Sigma-Tau S.p.A. Product Positions/Portfolio
                8.9.5 Sigma-Tau S.p.A. Key Developments
        8.4.10 Taiho Pharmaceutical Co., Ltd.
                8.10.1 Business Description
                8.10.2 Taiho Pharmaceutical Co., Ltd. Geographic Operations
                8.10.3 Taiho Pharmaceutical Co., Ltd. Financial Information
                8.10.4 Taiho Pharmaceutical Co., Ltd. Product Positions/Portfolio
                8.10.5 Taiho Pharmaceutical Co., Ltd. Key Developments
        8.4.11 Vertex Pharmaceuticals Incorporated
                8.11.1 Business Description
                8.11.2 Vertex Pharmaceuticals Incorporated Geographic Operations
                8.11.3 Vertex Pharmaceuticals Incorporated Financial Information
                8.11.4 Vertex Pharmaceuticals Incorporated Product Positions/Portfolio
                8.11.5 Vertex Pharmaceuticals Incorporated Key Developments
        8.4.12 Vichem Chemie Research Ltd.
                8.12.1 Business Description
                8.12.2 Vichem Chemie Research Ltd. Geographic Operations
                8.12.3 Vichem Chemie Research Ltd. Financial Information
                8.12.4 Vichem Chemie Research Ltd. Product Positions/Portfolio
                8.12.5 Vichem Chemie Research Ltd. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Aurora Kinase A Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Aurora Kinase A Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Aurora Kinase A Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Aurora Kinase A Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Aurora Kinase A Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Aurora Kinase A Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Aurora Kinase A Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Aurora Kinase A Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Aurora Kinase A Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Aurora Kinase A Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Aurora Kinase A Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Aurora Kinase A Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Aurora Kinase A Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Aurora Kinase A Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Aurora Kinase A Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Aurora Kinase A Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Aurora Kinase A: Market Segmentation 
FIG. 2 Global Aurora Kinase A Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Aurora Kinase A Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Aurora Kinase A Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Aurora Kinase A Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Aurora Kinase A Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Aurora Kinase A Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Aurora Kinase A Providers, 2019
FIG. 11 Global Aurora Kinase A Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Aurora Kinase A Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Aurora Kinase A Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Aurora Kinase A Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Aurora Kinase A Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Aurora Kinase A Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Aurora Kinase A Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Aurora Kinase A Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Aurora Kinase A market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1864

6898

OUR CLIENT